Excel Industries Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported a standalone revenue of ₹233 Crores for Q3 FY26, marking a significant 19% year-on-year increase. This growth was primarily driven by improved demand for key products in the performance solutions and YP derivatives segments, coupled with better price realization for certain products. Capacity expansion in one of the biocides also contributed to volume growth in performance solutions. The company's EBITDA margins stood at 7.3% (adjusted) for Q3 FY26, a 100 basis points improvement over the previous year, attributed to higher price realization and a favorable product mix. The Profit After Tax (PAT) for the quarter was ₹8 Crores. For the nine months ended December 31, 2025 (9M FY26), revenue reached ₹813 Crores, an 11% increase year-on-year, with an adjusted EBITDA margin of 11.0% and a PAT of ₹61 Crores. Exports constituted 27.0% and 22.3% of the total revenue in Q3 and 9M FY26, respectively. The company continues to focus on maintaining its market share in key products and diversifying its product portfolio. The financial statements also indicated that EBITDA was adjusted for a one-time impact of past service liability (gratuity) of ₹1.15 Crores due to new labor codes.
